BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29344610)

  • 1. Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences.
    Jones HJ; Gage SH; Heron J; Hickman M; Lewis G; Munafò MR; Zammit S
    JAMA Psychiatry; 2018 Mar; 75(3):240-246. PubMed ID: 29344610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children.
    Gage SH; Hickman M; Heron J; Munafò MR; Lewis G; Macleod J; Zammit S
    Psychol Med; 2014 Dec; 44(16):3435-44. PubMed ID: 25066001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence.
    Hines LA; Freeman TP; Gage SH; Zammit S; Hickman M; Cannon M; Munafo M; MacLeod J; Heron J
    JAMA Psychiatry; 2020 Oct; 77(10):1044-1051. PubMed ID: 32459328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring.
    Zammit S; Thomas K; Thompson A; Horwood J; Menezes P; Gunnell D; Hollis C; Wolke D; Lewis G; Harrison G
    Br J Psychiatry; 2009 Oct; 195(4):294-300. PubMed ID: 19794196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Trauma Type, Age of Exposure, and Frequency in Childhood and Adolescence With Psychotic Experiences in Early Adulthood.
    Croft J; Heron J; Teufel C; Cannon M; Wolke D; Thompson A; Houtepen L; Zammit S
    JAMA Psychiatry; 2019 Jan; 76(1):79-86. PubMed ID: 30477014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
    Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
    J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
    van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
    Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood academic ability in relation to cigarette, alcohol and cannabis use from adolescence into early adulthood: Longitudinal Study of Young People in England (LSYPE).
    Williams J; Hagger-Johnson G
    BMJ Open; 2017 Feb; 7(2):e012989. PubMed ID: 28228447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey.
    van Gastel WA; Wigman JT; Monshouwer K; Kahn RS; van Os J; Boks MP; Vollebergh WA
    Addiction; 2012 Feb; 107(2):381-7. PubMed ID: 21851445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests of causal linkages between cannabis use and psychotic symptoms.
    Fergusson DM; Horwood LJ; Ridder EM
    Addiction; 2005 Mar; 100(3):354-66. PubMed ID: 15733249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the association between tobacco and cannabis use and cognitive functioning: Findings from an observational and Mendelian randomization study.
    Mahedy L; Wootton R; Suddell S; Skirrow C; Field M; Heron J; Hickman M; Munafò MR
    Drug Alcohol Depend; 2021 Apr; 221():108591. PubMed ID: 33618197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cannabis and cigarette use with depression and anxiety at age 18: findings from the Avon Longitudinal Study of Parents and Children.
    Gage SH; Hickman M; Heron J; Munafò MR; Lewis G; Macleod J; Zammit S
    PLoS One; 2015; 10(4):e0122896. PubMed ID: 25875443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis dependence and psychotic symptoms in young people.
    Fergusson DM; Horwood LJ; Swain-Campbell NR
    Psychol Med; 2003 Jan; 33(1):15-21. PubMed ID: 12537032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort.
    Stefanis NC; Dragovic M; Power BD; Jablensky A; Castle D; Morgan VA
    Schizophr Res; 2014 Jul; 156(2-3):211-6. PubMed ID: 24831390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
    Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
    JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal substance use and the development of a DSM-IV cannabis use disorder during adolescence: the TRAILS study.
    Prince van Leeuwen A; Creemers HE; Verhulst FC; Vollebergh WA; Ormel J; van Oort F; Huizink AC
    Addiction; 2014 Feb; 109(2):303-11. PubMed ID: 24033662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.
    Compton MT; Kelley ME; Ramsay CE; Pringle M; Goulding SM; Esterberg ML; Stewart T; Walker EF
    Am J Psychiatry; 2009 Nov; 166(11):1251-7. PubMed ID: 19797432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are psychotic-like experiences related to a discontinuation of cannabis consumption in young adults?
    Daedelow LS; Banaschewski T; Berning M; Bokde ALW; Brühl R; Burke Quinlan E; Curran HV; Desrivières S; Flor H; Grigis A; Garavan H; Hardon A; Kaminski J; Martinot JL; Paillère Martinot ML; Artiges E; Murray H; Nees F; Oei NYL; Papadopoulos Orfanos D; Paus T; Poustka L; Hohmann S; Millenet S; Rosenthal A; Fröhner JH; Smolka MN; Walter H; Whelan R; Wiers RW; Schumann G; Heinz A; ;
    Schizophr Res; 2021 Feb; 228():271-279. PubMed ID: 33493775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.